NCYT:LON
Novacyt SA
GBX 39.50
arrow_downward
-0.25%(-0.100) 1 دن
16 اکتوبر, 4:35:25 PM GMT +1 · GBX
search
تمام علامات
| علامت | قیمت | تبدیلی | % تبدیلی |
|---|
insights_autoNCYT کے لیے سرفہرست بصیرتیں تخلیق کی جا رہی ہیں...
کھولیں
GBX 39.60
اعلی
GBX 39.68
کم
GBX 39.20
مارکیٹ کی سرمایہ کاری
3.24 کروڑ
اوسط والیوم
1.03 لاکھ
والیوم
12.22 ہزار
52 ہفتے میں اعلی
GBX 86.00
52 ہفتے کا کم
GBX 26.60
بقایہ شیئرز
3.77 کروڑ
ملازمین کی تعداد
228
کھولیں
GBX 39.60
اعلی
GBX 39.68
کم
GBX 39.20
مارکیٹ کی سرمایہ کاری
3.24 کروڑ
اوسط والیوم
1.03 لاکھ
والیوم
12.22 ہزار
52 ہفتے میں اعلی
GBX 86.00
52 ہفتے کا کم
GBX 26.60
بقایہ شیئرز
3.77 کروڑ
ملازمین کی تعداد
228
خبریں اور کہانیاں
ویب ذرائع اور خبروں کے پارٹنرز سے
WXXV News 25
·
38 منٹ پہلے
US markets are weighed down by an extended sell-off in the tech sector
MarketWatch
·
6 گھنٹے پہلے
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
Yahoo Finance
·
2 گھنٹے پہلے
Dow (DOW) Stock Could Look Reasonable After a 43% Gain
پروفائل
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
Novacyt SA کے بارے میں